Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.

Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK.

J Clin Oncol. 2005 Sep 20;23(27):6474-80. Epub 2005 Aug 22.

PMID:
16116154
2.

[Management strategy in neuroblastoma].

Balwierz W.

Przegl Lek. 2004;61 Suppl 2:3-8. Review. Polish.

PMID:
15686038
3.

Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience.

Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL.

Am J Hematol. 2003 Jan;72(1):53-63. Review.

4.

Fibrolamellar hepatocellular carcinoma in children and adolescents.

Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.

Cancer. 2003 Apr 15;97(8):2006-12. Review.

5.

Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.

Warnat P, Oberthuer A, Fischer M, Westermann F, Eils R, Brors B.

BMC Cancer. 2007 May 25;7:89. Review.

6.

Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.

van Noesel MM, Hählen K, Hakvoort-Cammel FG, Egeler RM.

Cancer. 1997 Sep 1;80(5):834-43. Review.

PMID:
9307181
7.

[Neuroblastoma].

Sawada T, Komatsu H, Shirai C, Yamamoto S, Ishiwari K, Ishida H, Ohmizono Y, Matsumura T.

Gan To Kagaku Ryoho. 1995 Jan;22(1):28-36. Review. Japanese.

PMID:
7826075
8.

Risk-based management: current concepts of treating malignant solid tumors of childhood.

Grosfeld JL.

J Am Coll Surg. 1999 Oct;189(4):407-25. Review.

PMID:
10509467
9.

A comparison of current neuroblastoma chemotherapeutics.

Castel V, Cañete A.

Expert Opin Pharmacother. 2004 Jan;5(1):71-80. Review.

PMID:
14680437
10.

Overview of current treatment of neuroblastoma.

Philip T.

Am J Pediatr Hematol Oncol. 1992 May;14(2):97-102. Review.

PMID:
1382390
11.

[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].

Pérel Y, Valteau-Couanet D, Michon J, Lavrand F, Coze C, Bergeron C, Notz A, Plantaz D, Chastagner P, Bernard F, Thomas C, Rubie H.

Arch Pediatr. 2004 Jul;11(7):834-42. Review. French.

PMID:
15234382
12.

Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.

Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M.

J Clin Oncol. 1998 Oct;16(10):3286-94. Review.

PMID:
9779703
13.

Current biologic and therapeutic implications in the surgery of neuroblastoma.

Azizkhan RG, Haase GM.

Semin Surg Oncol. 1993 Nov-Dec;9(6):493-501. Review.

PMID:
8284568
14.
15.

Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.

Grosfeld JL, Rescorla FJ, West KW, Goldman J.

Semin Pediatr Surg. 1993 Feb;2(1):37-46. Review.

PMID:
8062021
16.

Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma.

Matthay KK.

Pediatr Transplant. 1999;3 Suppl 1:72-7. Review.

PMID:
10587975
17.

[4S neuroblastoma with bilateral adrenal tumors].

Kerdudo C, Corradini N, Michon J, Leverger G.

Arch Pediatr. 2004 Dec;11(12):1450-6. Review. French.

PMID:
15596333
18.

Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.

George RE, Variend S, Cullinane C, Cotterill SJ, McGuckin AG, Ellershaw C, Lunec J, Pearson AD; United Kingdom Children Cancer Study Group.

Med Pediatr Oncol. 2001 Jan;36(1):169-76. Review.

PMID:
11464876
19.

Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?

Scott D, Elsden J, Pearson A, Lunec J.

Cancer Lett. 2003 Jul 18;197(1-2):81-6. Review.

PMID:
12880964
20.

Neuroblastomas in Denmark 1943-80. Epidemiological and clinical studies.

Carlsen NL.

Acta Paediatr Suppl. 1994 Oct;403:1-27. Review.

PMID:
7841631

Supplemental Content

Support Center